Agenus
AGEN
$8.30
Share price
11.86%
Change (1 day)
406.10%
Change (1 year)
Categories
EPS for Agenus (AGEN)
EPS in 2023 (TTM): -$0.85
According to Agenus 's latest financial reports the company's current EPS (TTM) is -$0.85. In 2022 the company made an earnings per share (EPS) of -$0.79 a decrease over its 2021 EPS that were of -$0.18.
EPS history for Agenus from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.85 | 7.59% |
| 2022 | -$0.79 | 338.89% |
| 2021 | -$0.18 | -82.86% |
| 2020 | -$1.05 | 32.91% |
| 2019 | -$0.79 | -45.89% |
| 2018 | -$1.46 | 19.67% |
| 2017 | -$1.22 | -17.01% |
| 2016 | -$1.47 | 27.83% |
| 2015 | -$1.15 | 69.12% |
| 2014 | -$0.68 | -40.87% |
| 2013 | -$1.15 | 134.69% |
| 2012 | -$0.49 | -59.5% |
| 2011 | -$1.21 | -14.18% |
| 2010 | -$1.41 | -41.25% |
| 2009 | -$2.40 | -20% |
| 2008 | -$3.00 | -38.27% |
| 2007 | -$4.86 | -29.57% |
| 2006 | -$6.90 | -29.88% |
| 2005 | -$9.84 | 29.13% |
| 2004 | -$7.62 | -25.29% |
| 2003 | -$10.20 | -0.58% |
| 2002 | -$10.26 | -33.72% |
| 2001 | -$15.48 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -1,757.09% | 🇺🇸 USA |
 Merck MRK | $1.82 | -314.32% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -567.06% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -511.85% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | -$2.40 | 182.35% | 🇺🇸 USA |